BK Polyomavirus microRNA in Kidney Transplant Recipient.

Is Compensation Prediction Score Valid for Contralateral Kidney After Living-Donor Nephrectomy in the United States?

HIV in kidney transplantation.

The Case For Cadmium and Lead Heavy Metal Screening.

Casirivimab-imdevimab for Treatment of COVID-19 in Solid Organ Transplant Recipients: An Early Experience.

Heavy Metal Toxicity in Chronic Renal Failure and Cardiovascular Disease: Possible Role for Chelation Therapy.

Obesity in Kidney Transplantation: Impact on Transplant Candidates, Recipients, and Donors.

Hypertension in the Kidney Transplant Recipient: Overview of Pathogenesis, Clinical Assessment, and Treatment.

Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.

Cardiovascular risk assessment before and after kidney transplantation.

The role of nonpharmacologic device interventions in the management of drug-resistant hypertension.

Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients.

Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients.

Effect of risedronate on bone in renal transplant recipients.

Fludrocortisone therapy in renal transplant recipients with persistent hyperkalemia.